DOCSLIB.ORG

KCND3 Potassium Channel Gene Variant Confers Susceptibility to Electrocardiographic Early Repolarization Pattern

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
KCND3 Potassium Channel Gene Variant Confers Susceptibility to Electrocardiographic Early Repolarization Pattern KCND3 potassium channel gene variant confers susceptibility to electrocardiographic early repolarization pattern Alexander Teumer, … , Elijah R. Behr, Wibke Reinhard JCI Insight. 2019. https://doi.org/10.1172/jci.insight.131156. Clinical Medicine In-Press Preview Cardiology Genetics Graphical abstract Find the latest version: https://jci.me/131156/pdf 1 KCND3 potassium channel gene variant confers susceptibility to 2 electrocardiographic early repolarization pattern 3 Alexander Teumer1,2*, Teresa Trenkwalder3*, Thorsten Kessler3, Yalda Jamshidi4, Marten E. van den 4 Berg5, Bernhard Kaess6, Christopher P. Nelson7,8, Rachel Bastiaenen9, Marzia De Bortoli10, 5 Alessandra Rossini10, Isabel Deisenhofer3, Klaus Stark11, Solmaz Assa12, Peter S. Braund7,8, Claudia 6 Cabrera13,14,15, Anna F. Dominiczak16, Martin Gögele10, Leanne M. Hall7,8, M. Arfan Ikram5, Maryam 7 Kavousi5, Karl J. Lackner17,18, Lifelines Cohort Study19, Christian Müller20, Thomas Münzel18,21, 8 Matthias Nauck2,22, Sandosh Padmanabhan16, Norbert Pfeiffer23, Tim D. Spector24, Andre G. 9 Uitterlinden5, Niek Verweij12, Uwe Völker2,25, Helen R. Warren13,14, Mobeen Zafar12, Stephan B. 10 Felix2,26, Jan A. Kors27, Harold Snieder28, Patricia B. Munroe13,14, Cristian Pattaro10, Christian 11 Fuchsberger10, Georg Schmidt29,30, Ilja M. Nolte28, Heribert Schunkert3,30, Peter Pramstaller10, Philipp 12 S. Wild31, Pim van der Harst12, Bruno H. Stricker5, Renate B. Schnabel20, Nilesh J. Samani7,8, 13 Christian Hengstenberg32, Marcus Dörr2,26, Elijah R. Behr33, Wibke Reinhard3 14 15 16 1 Institute for Community Medicine, University Medicine Greifswald, Germany 17 2 DZHK (German Center for Cardiovascular Research), partner site Greifswald, Greifswald, Germany 18 3 Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, School of Medicine, 19 Technical University of Munich, Munich, Germany 20 4 Genetics Research Centre, Institute of Molecular and Clinical Sciences, St George's University of 21 London, United Kingdom 22 5 Department of Epidemiology, Erasmus MC - University Medical Center Rotterdam, The Netherlands 23 6 Medizinische Klinik I, St. Josefs-Hospital, Wiesbaden, Germany 24 7 Department of Cardiovascular Sciences, Cardiovascular Research Centre, Leicester, Leicester, 25 United Kingdom 26 8 NIHR Leicester Biomedical Research Centre University of Leicester, Leicester, United Kingdom 27 9 Cardiology Clinial Academic Group, Institute of Molecular and Clinical Sciences, St George's, 28 University of London, United Kingdom 29 10 Institute for Biomedicine, Eurac Research, affiliated with the University of Lübeck, Bolzano, Italy 30 11 Department of Genetic Epidemiology, University Regensburg, Germany 31 12 Department of Cardiology, University of Groningen, University Medical Center Groningen, The 32 Netherlands 33 13 Clinical Pharmacology, William Harvey Research Institute, Barts and The London, Queen Mary 34 University of London, London, UK 35 14 NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of 36 Medicine and Dentistry, Queen Mary University of London, London, UK 37 15 Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London 38 School of Medicine and Dentistry, Charterhouse Square, London, UK 39 16 Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, 40 University of Glasgow, Glasgow, Scotland, UK 41 17 Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes 42 Gutenberg-University Mainz, Mainz, Germany 43 18 German Center for Cardiovascular Research (DZHK), partner site RhineMain, Mainz, Germany 44 19 The list of the Lifelines Cohort Study group authors is provided in the study acknowledgments 45 20 Department of General and Interventional Cardiology, University Heart Center Hamburg- 46 Eppendorf, Germany, DZHK (German Center for Cardiovascular Research), partner site 47 Hamburg/Kiel/Lübeck, Germany 48 21 Center for Cardiology - Cardiology I, University Medical Center of the Johannes Gutenberg- 49 University Mainz, Mainz, Germany 50 22 Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, 51 Greifswald, Germany 52 23 Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University 53 Mainz, Mainz, Germany 54 24 Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK 55 25 Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, 56 Greifswald, Germany 57 26 Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany 58 27 Department of Medical Informatics, Erasmus MC - University Medical Center Rotterdam, The 59 Netherlands 1 60 28 Department of Epidemiology, University of Groningen, University Medical Center Groningen, 61 Groningen, The Netherlands 62 29 Innere Medizin I, Klinikum rechts der Isar, Technical University Munich, Munich, Germany 63 30 Deutsches Zentrum für Herz- und Kreislauf-Forschung (DZHK) e.V. (German Center for 64 Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany 65 31 Preventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center 66 of the Johannes Gutenberg-University Mainz, Mainz, Germany; Center for Thrombosis and 67 Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, 68 Germany; DZHK (German Center for Cardiovascular Research), partner site Rhine-Main, Mainz, 69 Germany 70 32 Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, 71 Austria 72 33 Cardiology Clinical Academic Group, Institute of Molecular and Clinical Sciences, St George's, 73 University of London, United Kingdom AND St George's University Hospitals NHS Foundation Trust, 74 London, United Kingdom 75 76 * These authors contributed equally to this work. 77 78 Corresponding Author: 79 PD Dr. med. Wibke Reinhard 80 Klinik für Herz- und Kreislauferkrankungen 81 Deutsches Herzzentrum München, Technische Universität München 82 Lazarettstrasse 36 83 80636 München 84 Germany 85 tel: +49 89 1218 4025 86 email: [email protected] 87 88 89 2 90 Abstract 91 Background. The presence of an early repolarization pattern (ERP) on the surface electrocardiogram 92 (ECG) is associated with risk of ventricular fibrillation and sudden cardiac death. Family studies have 93 shown that ERP is a highly heritable trait but molecular genetic determinants are unknown. 94 Methods. To identify genetic susceptibility loci for ERP, we performed a GWAS and meta-analysis in 95 2,181 cases and 23,641 controls of European ancestry. 96 Results. We identified a genome-wide significant (p<5E-8) locus in the KCND3 (potassium voltage 97 gated channel subfamily D member 3) gene that was successfully replicated in additional 1,124 cases 98 and 12,510 controls. A subsequent joint meta-analysis of the discovery and replication cohorts 99 identified rs1545300 as the lead SNP at the KCND3 locus (OR 0.82 per minor T allele, p=7.7E-12), 100 but did not reveal additional loci. Co-localization analyses indicate causal effects of KCND3 gene 101 expression levels on ERP in both cardiac left ventricle and tibial artery. 102 Conclusions. In this study we identified for the first time a genome-wide significant association of a 103 genetic variant with ERP. Our findings of a locus in the KCND3 gene not only provide insights into the 104 genetic determinants but also into the pathophysiological mechanism of ERP, discovering a promising 105 candidate for functional studies. 106 Funding. For detailed information per study, see Acknowledgments. 3 107 Introduction 108 The early repolarization pattern (ERP) is a common ECG finding characterized by an elevation at the 109 QRS-ST junction (J-point) of at least 0.1 mV in two adjacent ECG leads. The prevalence of ERP in the 110 general population ranges from 2 to 13% being more common in young athletic men(1–5). The 111 classical notion of ERP being a benign ECG phenotype was challenged in 2008 by the landmark study 112 of Haissaguerre and colleagues showing an association of ERP with increased risk of ventricular 113 fibrillation and sudden cardiac death(6): the Early Repolarization Syndrome (ERS)(7). Since then 114 several studies demonstrated an elevated risk of cardiovascular and all-cause mortality in individuals 115 with ERP underscoring its arrhythmogenic potential(2, 8, 9). Although the mechanistic basis for 116 malignant arrhythmias in ERS is unclear, it has been suggested that they occur as a result of an 117 augmented transmural electrical dispersion of repolarization(10). Ex vivo studies point towards a 118 central role of the cardiac transient outward potassium current (Ito) in the development of both, ERP 119 and ERS(11). Furthermore, candidate genetic association studies have highlighted a role for several 120 genes encoding cardiac ion channels in the development of ERP and ERS(12–15). These genes 121 include gain-of-function variants in IK-ATP channels (KCNJ8, ABCC9) and loss-of-function variants in 122 cardiac L-type calcium channels (CACNA1C, CACNB2b, CACNA2D1) and sodium channels (SCN5A, 123 SCN10A)(16). Interestingly, co-existence of two genetic variants in different ion channel genes with 124 opposing effects can be observed leading to phenotypic incomplete penetrance of ERP(15). However, 125 data from functional studies confirming causality are scarce(17). 126 Studies among relatives of sudden arrhythmic
Load more

Recommended publications
  • Towards Mutation-Specific Precision Medicine in Atypical Clinical
    International Journal of Molecular Sciences Review Towards Mutation-Specific Precision Medicine in Atypical Clinical Phenotypes of Inherited Arrhythmia Syndromes Tadashi Nakajima * , Shuntaro Tamura, Masahiko Kurabayashi and Yoshiaki Kaneko Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi 371-8511, Gunma, Japan; [email protected] (S.T.); [email protected] (M.K.); [email protected] (Y.K.) * Correspondence: [email protected]; Tel.: +81-27-220-8145; Fax: +81-27-220-8158 Abstract: Most causal genes for inherited arrhythmia syndromes (IASs) encode cardiac ion channel- related proteins. Genotype-phenotype studies and functional analyses of mutant genes, using heterol- ogous expression systems and animal models, have revealed the pathophysiology of IASs and enabled, in part, the establishment of causal gene-specific precision medicine. Additionally, the utilization of induced pluripotent stem cell (iPSC) technology have provided further insights into the patho- physiology of IASs and novel promising therapeutic strategies, especially in long QT syndrome. It is now known that there are atypical clinical phenotypes of IASs associated with specific mutations that have unique electrophysiological properties, which raises a possibility of mutation-specific precision medicine. In particular, patients with Brugada syndrome harboring an SCN5A R1632C mutation exhibit exercise-induced cardiac events, which may be caused by a marked activity-dependent loss of R1632C-Nav1.5 availability due to a marked delay of recovery from inactivation. This suggests that the use of isoproterenol should be avoided. Conversely, the efficacy of β-blocker needs to be examined. Patients harboring a KCND3 V392I mutation exhibit both cardiac (early repolarization syndrome and Citation: Nakajima, T.; Tamura, S.; paroxysmal atrial fibrillation) and cerebral (epilepsy) phenotypes, which may be associated with a Kurabayashi, M.; Kaneko, Y.
    [Show full text]
  • Expression Profiling of Ion Channel Genes Predicts Clinical Outcome in Breast Cancer
    UCSF UC San Francisco Previously Published Works Title Expression profiling of ion channel genes predicts clinical outcome in breast cancer Permalink https://escholarship.org/uc/item/1zq9j4nw Journal Molecular Cancer, 12(1) ISSN 1476-4598 Authors Ko, Jae-Hong Ko, Eun A Gu, Wanjun et al. Publication Date 2013-09-22 DOI http://dx.doi.org/10.1186/1476-4598-12-106 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Ko et al. Molecular Cancer 2013, 12:106 http://www.molecular-cancer.com/content/12/1/106 RESEARCH Open Access Expression profiling of ion channel genes predicts clinical outcome in breast cancer Jae-Hong Ko1, Eun A Ko2, Wanjun Gu3, Inja Lim1, Hyoweon Bang1* and Tong Zhou4,5* Abstract Background: Ion channels play a critical role in a wide variety of biological processes, including the development of human cancer. However, the overall impact of ion channels on tumorigenicity in breast cancer remains controversial. Methods: We conduct microarray meta-analysis on 280 ion channel genes. We identify candidate ion channels that are implicated in breast cancer based on gene expression profiling. We test the relationship between the expression of ion channel genes and p53 mutation status, ER status, and histological tumor grade in the discovery cohort. A molecular signature consisting of ion channel genes (IC30) is identified by Spearman’s rank correlation test conducted between tumor grade and gene expression. A risk scoring system is developed based on IC30. We test the prognostic power of IC30 in the discovery and seven validation cohorts by both Cox proportional hazard regression and log-rank test.
    [Show full text]
  • Investigating Unexplained Deaths for Molecular Autopsies
    The author(s) shown below used Federal funding provided by the U.S. Department of Justice to prepare the following resource: Document Title: Investigating Unexplained Deaths for Molecular Autopsies Author(s): Yingying Tang, M.D., Ph.D, DABMG Document Number: 255135 Date Received: August 2020 Award Number: 2011-DN-BX-K535 This resource has not been published by the U.S. Department of Justice. This resource is being made publically available through the Office of Justice Programs’ National Criminal Justice Reference Service. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. Final Technical Report NIJ FY 11 Basic Science Research to Support Forensic Science 2011-DN-BX-K535 Investigating Unexplained Deaths through Molecular Autopsies May 28, 2017 Yingying Tang, MD, PhD, DABMG Principal Investigator Director, Molecular Genetics Laboratory Office of Chief Medical Examiner 421 East 26th Street New York, NY, 10016 Tel: 212-323-1340 Fax: 212-323-1540 Email: [email protected] Page 1 of 41 This resource was prepared by the author(s) using Federal funds provided by the U.S. Department of Justice. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. Abstract Sudden Unexplained Death (SUD) is natural death in a previously healthy individual whose cause remains undetermined after scene investigation, complete autopsy, and medical record review. SUD affects children and adults, devastating families, challenging medical examiners, and is a focus of research for cardiologists, neurologists, clinical geneticists, and scientists.
    [Show full text]
  • Atrial Fibrillation (ATRIA) Study
    European Journal of Human Genetics (2014) 22, 297–306 & 2014 Macmillan Publishers Limited All rights reserved 1018-4813/14 www.nature.com/ejhg REVIEW Atrial fibrillation: the role of common and rare genetic variants Morten S Olesen*,1,2,4, Morten W Nielsen1,2,4, Stig Haunsø1,2,3 and Jesper H Svendsen1,2,3 Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting 1–2% of the general population. A number of studies have demonstrated that AF, and in particular lone AF, has a substantial genetic component. Monogenic mutations in lone and familial AF, although rare, have been recognized for many years. Presently, mutations in 25 genes have been associated with AF. However, the complexity of monogenic AF is illustrated by the recent finding that both gain- and loss-of-function mutations in the same gene can cause AF. Genome-wide association studies (GWAS) have indicated that common single-nucleotide polymorphisms (SNPs) have a role in the development of AF. Following the first GWAS discovering the association between PITX2 and AF, several new GWAS reports have identified SNPs associated with susceptibility of AF. To date, nine SNPs have been associated with AF. The exact biological pathways involving these SNPs and the development of AF are now starting to be elucidated. Since the first GWAS, the number of papers concerning the genetic basis of AF has increased drastically and the majority of these papers are for the first time included in a review. In this review, we discuss the genetic basis of AF and the role of both common and rare genetic variants in the susceptibility of developing AF.
    [Show full text]
  • Renal Membrane Transport Proteins and the Transporter Genes
    Techno e lo n g Gowder, Gene Technology 2014, 3:1 e y G Gene Technology DOI; 10.4172/2329-6682.1000e109 ISSN: 2329-6682 Editorial Open Access Renal Membrane Transport Proteins and the Transporter Genes Sivakumar J T Gowder* Qassim University, College of Applied Medical Sciences, Buraidah, Kingdom of Saudi Arabia Kidney this way, high sodium diet favors urinary sodium concentration [9]. AQP2 has a role in hereditary and acquired diseases affecting urine- In humans, the kidneys are a pair of bean-shaped organs about concentrating mechanisms [10]. AQP2 regulates antidiuretic action 10 cm long and located on either side of the vertebral column. The of arginine vasopressin (AVP). The urinary excretion of this protein is kidneys constitute for less than 1% of the weight of the human body, considered to be an index of AVP signaling activity in the renal system. but they receive about 20% of blood pumped with each heartbeat. The Aquaporins are also considered as markers for chronic renal allograft renal artery transports blood to be filtered to the kidneys, and the renal dysfunction [11]. vein carries filtered blood away from the kidneys. Urine, the waste fluid formed within the kidney, exits the organ through a duct called the AQP4 ureter. The kidney is an organ of excretion, transport and metabolism. This gene encodes a member of the aquaporin family of intrinsic It is a complicated organ, comprising various cell types and having a membrane proteins. These proteins function as water-selective channels neatly designed three dimensional organization [1]. Due to structural in the plasma membrane.
    [Show full text]
  • Ion Channels 3 1
    r r r Cell Signalling Biology Michael J. Berridge Module 3 Ion Channels 3 1 Module 3 Ion Channels Synopsis Ion channels have two main signalling functions: either they can generate second messengers or they can function as effectors by responding to such messengers. Their role in signal generation is mainly centred on the Ca2 + signalling pathway, which has a large number of Ca2+ entry channels and internal Ca2+ release channels, both of which contribute to the generation of Ca2 + signals. Ion channels are also important effectors in that they mediate the action of different intracellular signalling pathways. There are a large number of K+ channels and many of these function in different + aspects of cell signalling. The voltage-dependent K (KV) channels regulate membrane potential and + excitability. The inward rectifier K (Kir) channel family has a number of important groups of channels + + such as the G protein-gated inward rectifier K (GIRK) channels and the ATP-sensitive K (KATP) + + channels. The two-pore domain K (K2P) channels are responsible for the large background K current. Some of the actions of Ca2 + are carried out by Ca2+-sensitive K+ channels and Ca2+-sensitive Cl − channels. The latter are members of a large group of chloride channels and transporters with multiple functions. There is a large family of ATP-binding cassette (ABC) transporters some of which have a signalling role in that they extrude signalling components from the cell. One of the ABC transporters is the cystic − − fibrosis transmembrane conductance regulator (CFTR) that conducts anions (Cl and HCO3 )and contributes to the osmotic gradient for the parallel flow of water in various transporting epithelia.
    [Show full text]
  • Spatial Distribution of Leading Pacemaker Sites in the Normal, Intact Rat Sinoa
    Supplementary Material Supplementary Figure 1: Spatial distribution of leading pacemaker sites in the normal, intact rat sinoatrial 5 nodes (SAN) plotted along a normalized y-axis between the superior vena cava (SVC) and inferior vena 6 cava (IVC) and a scaled x-axis in millimeters (n = 8). Colors correspond to treatment condition (black: 7 baseline, blue: 100 µM Acetylcholine (ACh), red: 500 nM Isoproterenol (ISO)). 1 Supplementary Figure 2: Spatial distribution of leading pacemaker sites before and after surgical 3 separation of the rat SAN (n = 5). Top: Intact SAN preparations with leading pacemaker sites plotted during 4 baseline conditions. Bottom: Surgically cut SAN preparations with leading pacemaker sites plotted during 5 baseline conditions (black) and exposure to pharmacological stimulation (blue: 100 µM ACh, red: 500 nM 6 ISO). 2 a &DUGLDFIoQChDQQHOV .FQM FOXVWHU &DFQDG &DFQDK *MD &DFQJ .FQLS .FQG .FQK .FQM &DFQDF &DFQE .FQM í $WSD .FQD .FQM í .FQN &DVT 5\U .FQM &DFQJ &DFQDG ,WSU 6FQD &DFQDG .FQQ &DFQDJ &DFQDG .FQD .FQT 6FQD 3OQ 6FQD +FQ *MD ,WSU 6FQE +FQ *MG .FQN .FQQ .FQN .FQD .FQE .FQQ +FQ &DFQDD &DFQE &DOP .FQM .FQD .FQN .FQG .FQN &DOP 6FQD .FQD 6FQE 6FQD 6FQD ,WSU +FQ 6FQD 5\U 6FQD 6FQE 6FQD .FQQ .FQH 6FQD &DFQE 6FQE .FQM FOXVWHU V6$1 L6$1 5$ /$ 3 b &DUGLDFReFHSWRUV $GUDF FOXVWHU $GUDD &DY &KUQE &KUP &KJD 0\O 3GHG &KUQD $GUE $GUDG &KUQE 5JV í 9LS $GUDE 7SP í 5JV 7QQF 3GHE 0\K $GUE *QDL $QN $GUDD $QN $QN &KUP $GUDE $NDS $WSE 5DPS &KUP 0\O &KUQD 6UF &KUQH $GUE &KUQD FOXVWHU V6$1 L6$1 5$ /$ 4 c 1HXURQDOPURWHLQV
    [Show full text]
  • Cardiac Arrest Is One of the Most Dramatic and Devastating Conditions in All of Cardiology
    UvA-DARE (Digital Academic Repository) Genetic aspects of cardiac arrythmia syndromes Postma, A.V. Publication date 2003 Document Version Final published version Link to publication Citation for published version (APA): Postma, A. V. (2003). Genetic aspects of cardiac arrythmia syndromes. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:04 Oct 2021 Genetic Aspects of Cardiac Arrhythmia Syndromes Genetic Aspects of Cardiac Arrhythmia Syndromes Alex V. Postma / University of Amsterdam, 2003 / Thesis Printed by Thela Thesis, Amsterdam ISBN 90-9017091-X Cover design by author © 2003 by Alex V. Postma No part of this thesis may be reproduced, stored in a retrieval system, or transmitted in any form or by any means without permission of the author.
    [Show full text]
  • Information Topology of Gene Expression Profile in Dopaminergic Neurons
    bioRxiv preprint doi: https://doi.org/10.1101/168740; this version posted July 26, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Information topology of gene expression profile in dopaminergic neurons 2 Mónica TAPIA PACHECO1,§, Pierre BAUDOT1,§, Martial A. DUFOUR1,2, Christine 3 FORMISANO-TRÉZINY1, Simone TEMPORAL1, Manon LASSERRE1, Jean 4 GABERT1,3, Kazuto KOBAYASHI4 and Jean-Marc GOAILLARD1,5 5 6 1 Unité de Neurobiologie des Canaux Ioniques et de la Synapse, INSERM UMR 7 1072, Aix Marseille Université, 13015 Marseille, FRANCE 8 2 Current address: NYU Neuroscience Institute, New York University, New York, 9 NY 10016, USA 10 3 Department of Biochemistry & Molecular Biology, University Hospital Nord, 11 Marseille, FRANCE 12 4 Department of Molecular Genetics, Institute of Biomedical Sciences, Fukushima 13 Medical University, Fukushima, 960-1295, JAPAN 14 5 Corresponding author 15 § These authors contributed equally to this work 16 17 Author contributions: M.T.P, P.B., C.F.T. and J.M.G. designed research. M.T.P., 18 P.B., C.F.T., M.A.D., S.T., M.L., J.G., K.K. and J.M.G. performed research. M.T.P., 19 P.B., C.F.T. and J.M.G. analyzed data. M.T.P., P.B., C.F.T. and J.M.G. wrote the 20 manuscript. 21 Corresponding author: Jean-Marc GOAILLARD 22 UMR_S 1072, INSERM, Aix Marseille Université, Faculté de Médecine Secteur 23 Nord, Marseille, FRANCE. 24 Email: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/168740; this version posted July 26, 2017.
    [Show full text]
  • Exploration Into Biomarker Potential of Region-Specific Brain Gene Co
    www.nature.com/scientificreports OPEN Exploration into biomarker potential of region‑specifc brain gene co‑expression networks Yuqing Hang1, Mohammed Aburidi2, Benafsh Husain2, Allison R. Hickman1, William L. Poehlman1 & F. Alex Feltus1,2,3* The human brain is a complex organ that consists of several regions each with a unique gene expression pattern. Our intent in this study was to construct a gene co‑expression network (GCN) for the normal brain using RNA expression profles from the Genotype‑Tissue Expression (GTEx) project. The brain GCN contains gene correlation relationships that are broadly present in the brain or specifc to thirteen brain regions, which we later combined into six overarching brain mini‑GCNs based on the brain’s structure. Using the expression profles of brain region‑specifc GCN edges, we determined how well the brain region samples could be discriminated from each other, visually with t‑SNE plots or quantitatively with the Gene Oracle deep learning classifer. Next, we tested these gene sets on their relevance to human tumors of brain and non‑brain origin. Interestingly, we found that genes in the six brain mini‑GCNs showed markedly higher mutation rates in tumors relative to matched sets of random genes. Further, we found that cortex genes subdivided Head and Neck Squamous Cell Carcinoma (HNSC) tumors and Pheochromocytoma and Paraganglioma (PCPG) tumors into distinct groups. The brain GCN and mini‑GCNs are useful resources for the classifcation of brain regions and identifcation of biomarker genes for brain related phenotypes. Te human brain is a complex system encompassing countless cells that coalesce into hundreds of diferent regions and patterns of functional connectivity1.
    [Show full text]
  • Transcriptome Analysis Reveals Transmembrane Targets on Transplantable Midbrain Dopamine Progenitors
    Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors Chris R. Byea, Marie E. Jönssonb, Anders Björklundb,1, Clare L. Parisha, and Lachlan H. Thompsona,1 aFlorey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia 3010; and bWallenberg Neuroscience Centre, Department of Experimental Medical Science, Lund University, S-22184 Lund, Sweden Contributed by Anders Björklund, February 5, 2015 (sent for review December 8, 2014; reviewed by Eva Hedlund and Tilo Kunath) An important challenge for the continued development of cell targeting of cell-specific surface antigens as a means to separate therapy for Parkinson’s disease (PD) is the establishment of proce- defined cell fractions from mixed populations. Central to the dures that better standardize cell preparations for use in transplan- development of the technique was the identification of trans- tation. Although cell sorting has been an anticipated strategy, its membrane proteins that selectively define a target cell population. + + application has been limited by lack of knowledge regarding trans- For example, isolation of CD34 and Thy1 cells facilitates puri- membrane proteins that can be used to target and isolate progen- fication of hematopoietic stem cells that can reconstitute the he- itors for midbrain dopamine (mDA) neurons. We used a “FACS-array” matopoietic system as part of treatment for cancer patients (7–10). approach to identify 18 genes for transmembrane proteins with A current obstacle for the development of similar techniques for high expression in mDA progenitors and describe the utility of four the purification of specific neural progenitor phenotypes, in- of these targets (Alcam, Chl1, Gfra1, and Igsf8) for isolating mDA cluding mDA progenitors, is a lack of knowledge regarding the progenitors from rat primary ventral mesencephalon through flow identity of suitable transmembrane targets.
    [Show full text]
  • Gene List of the Targeted NGS MCD and CCA Gene Panel AKT3,ALX1
    Gene List of the targeted NGS MCD and CCA gene panel AKT3,ALX1,ALX3,ALX4,AMPD2,ARFGEF2,ARID1B,ARX,ASPM,ATR,ATRX,B3GALTL,BRPF1,c12orf57,C6orf70,CASK,CCND2,CDK5RAP2,CDON,C ENPJ,CEP170,CHMP1A,COL4A1,CREBBP,CYP11A1,DCHS1,DCLK1,DCX,DHCR24,DHCR7,DIS3L2,DISC1,DISP1,DLL1,DMRTA2,DYNC1H1,DYRK1 A,EARS2,EFNB1,EMX1,EOMES,EP300,ERBB4,ERMARD,EXOSC3,FAM36A,FGF8,FGFR1,FGFR2,FLNA,FOXC1,FOXG1,FOXH1,FZD10,GLI2,GLI3,GP R56,GPSM2,HCCS,HESX1,HNRNPU,IGBP1,IGFBP1,ISPD,ITPA,KAL1,KAT6B,KATNB1,KIAA1279,KIF14,KIF1A,KIF1B,KIF21A,KIF2A,KIF5C,KIF7,L1 CAM,LAMB1,LAMC3,LRP2,MCPH1,MED12,MID1,NDE1,NFIB,NPC1,NR2F1,NSD1,NTRK1,NTRK3,OCEL1,OPA1,OTX2,PAFAH1B1,PAX6,PEX1,PHF1 0,PIK3R2,POLR3A,POLR3B,POMT1,POMT2,PTCH1,PTPRS,PYCR1,RAB3GAP1,RARS2,RELN,RFX3,ROBO1,ROBO3,RPS6KA3,RTTN,SATB2,SEPSEC S,SHH,SIX3,SLC12A6,SOX2,SPOCK1,SRPX2,TBCD,TBCE,TCF4,TDGF1,TEAD1,THBS2,TMEM5,TSC1,TSC2,TSEN15,TSEN2,TSEN34,TSEN54,TUBA1 A,TUBA8,TUBB,TUBB2A,TUBB2B,TUBB3,TUBB4A,TUBG1,VAX1,VRK1,WDR47,WDR62,ZBTB18,ZEB2,ZIC2. Gene List of the targeted NGS epilepsy gene panel AARS, ADGRV1, ADRA2B, ADSL, ALDH4A1, ALDH7A1, ALG13, ALPL, ARHGEF15, ARHGEF9, ARX, ASAH1, ATP1A2, ATP1A3, BRD2, CACNA1A, CACNA1H, CACNA2D2, CACNB4, CBL, CDKL5, CERS1, CHD2, CHRNA2, CHRNA4, CHRNB2, CLCN2, CLCN4, CLN8, CLTC, CNKSR2, CNTNAP2, CPA6, CPLX1, CSNK1G1, CSNK2B, CTNND2, DEPDC5, DHDDS, DNM1, DOCK7, DYNC1H1, EEF1A2, EFHC1, EIF2S3, EMC1, EPM2A, FASN, FLNA, FOXG1, GABBR2, GABRA1, GABRA2, GABRA3, GABRB2, GABRB3, GABRD, GABRG2, GAL, GNAO1, GOSR2, GRIA1, GRIN1, GRIN2A, GRIN2B, HCN1, HCN4, HDAC4, HNRNPU, IDH3A, IQSEC2, JRK, KCNA1, KCNA2, KCNB1,
    [Show full text]